Clinical Trial Update: Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study update for Orca-T in recipients undergoing allogeneic transplantation for hematologic malignancies; the trial is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Blastic Plasmacytoid Dendritic Cell Neoplasm
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Orca-T

Snippet

Sponsor: Orca Biosystems, Inc. | Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING